No price history available.
Key financial summary
Financials in SGD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | SGDm | 1,830 | 3,082 | 1,260 | 915 | 1,073 | 958 | N/A | N/A |
| Operating profit | SGDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | SGDm | 647 | 1,418 | 314 | 220 | 287 | 200 | N/A | N/A |
| EPS reported | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | SGDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | SGDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | SGDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | SGD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in SGD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Riverstone Holdings Limited (AP4.SI)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.